Xenon Pharmaceuticals Inc (NASDAQ:XENE)
| 16.91 Delayed Data As of Feb 14 |  -0.66 / -3.76%Today’s Change | 7.58 Today|||52-Week Range 18.45 | +28.99% Year-to-Date |
Latest XENE News | Press Releases
| 3 Canadian Biotechs to Consider Buying Today Feb 07 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 17.57 |
| Today’s open | 17.73 |
| Day’s range | 16.38 - 17.99 |
| Volume | 440,933 |
| Average volume (3 months) | 201,433 |
| Market cap | $528.8M |
Data as of 4:00pm ET, 02/14/2020
Growth & Valuation
| Earnings growth (last year) | +4.82% |
| Earnings growth (this year) | 0.00% |
| Earnings growth (next 5 years) | +61.10% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.57 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CLVSClovis Oncology Inc | -0.27 | -2.78% |
| NLTXNeoleukin Therapeuti... | -0.98 | -8.14% |
| MISTMilestone Pharmaceut... | +0.88 | +4.38% |
| CRNXCrinetics Pharmaceut... | -0.19 | -0.84% |
Data as of 4:00pm ET, 02/14/2020
Financials
| Next reporting date | March 9, 2020 |
| EPS forecast (this quarter) | -$0.48 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$34.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Burnaby, British Columbia |
Forecasts
